Effect of oral monthly ibandronate on bone microarchitecture in women with osteopenia-a randomized placebo-controlled trial (Q43506698)

24 November 2017

title

Effect of oral monthly ibandronate on bone microarchitecture in women with osteopenia-a randomized placebo-controlled trial (English)

1 reference

24 November 2017

1 reference

R D Chapurlat

1

1 reference

24 November 2017

M Laroche

2

1 reference

24 November 2017

T Thomas

3

1 reference

24 November 2017

S Rouanet

4

1 reference

24 November 2017

P D Delmas

5

1 reference

24 November 2017

M-C de Vernejoul

6

1 reference

24 November 2017

language of work or name

English

0 references

publication date

9 March 2012

1 reference

Osteoporosis International

24 November 2017

published in

1 reference

24 November 2017

volume

24

1 reference

24 November 2017

issue

1

1 reference

24 November 2017

page(s)

311-320

1 reference

Identification and fracture outcomes of undiagnosed low bone mineral density in postmenopausal women: results from the National Osteoporosis Risk Assessment

24 November 2017

cites work

1 reference

https://api.crossref.org/works/10.1007%2FS00198-012-1947-4

In vivo assessment of trabecular bone microarchitecture by high-resolution peripheral quantitative computed tomography.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00198-012-1947-4

Correlation of trabecular bone structure with age, bone mineral density, and osteoporotic status: in vivo studies in the distal radius using high resolution magnetic resonance imaging

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00198-012-1947-4

Severity of vertebral fractures is associated with alterations of cortical architecture in postmenopausal women.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00198-012-1947-4

Alterations of cortical and trabecular architecture are associated with fractures in postmenopausal women, partially independent of decreased BMD measured by DXA: the OFELY study.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00198-012-1947-4

Relation of vertebral deformities to bone density, structure, and strength

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00198-012-1947-4

Risk of fracture among women who lose bone density during treatment with alendronate. The Fracture Intervention Trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00198-012-1947-4

Image-based assessment of spinal trabecular bone structure from high-resolution CT images

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00198-012-1947-4

Reconsidering the effects of antiresorptive therapies in reducing osteoporotic fracture

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00198-012-1947-4

Bone turnover matters: the raloxifene treatment paradox of dramatic decreases in vertebral fractures without commensurate increases in bone density

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00198-012-1947-4

A longitudinal HR-pQCT study of alendronate treatment in postmenopausal women with low bone density: Relations among density, cortical and trabecular microarchitecture, biomechanics, and bone turnover

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00198-012-1947-4

Microarchitectural deterioration of cortical and trabecular bone: differing effects of denosumab and alendronate.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00198-012-1947-4

Individual and combined effects of exercise and alendronate on bone mass and strength in ovariectomized rats

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00198-012-1947-4

Site-specific variation of bone micro-architecture in the distal radius and tibia

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00198-012-1947-4

The effects of geometric and threshold definitions on cortical bone metrics assessed by in vivo high-resolution peripheral quantitative computed tomography

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00198-012-1947-4

Alendronate increases bone strength by increasing the mean degree of mineralization of bone tissue in osteoporotic women

21 January 2018

1 reference

12 December 2020

Identification of osteopenic women at high risk of fracture: the OFELY study.

1 reference

12 December 2020

Changes in bone mineral density explain little of the reduction in vertebral or nonvertebral fracture risk with anti-resorptive therapy

1 reference

12 December 2020

Comparison of alendronate vs alendronate plus mechanical loading as prophylaxis for osteoporosis in lung transplant recipients: a pilot study

1 reference

12 December 2020

Structure analysis of high resolution magnetic resonance imaging of the proximal femur: in vitro correlation with biomechanical strength and BMD

1 reference

12 December 2020

10.1007/S00198-012-1947-4

Identifiers

DOI

1 reference

Dimensions Publication ID

24 November 2017

1041879589

0 references

1 reference